When a Test Feels Like the Final Answer
Many people with hypermobility and EDS are initially told that genetic testing is how you get a diagnosis. It can sound reassuring, like a definitive way to finally get some clarity about what is causing all these symptoms. But when results come back negative, it often leaves patients feeling confused, invalidated, or back at square one. The reality is more nuanced. Genetic testing can be helpful in some situations — but it is not the whole story.
Why Genetic Testing for EDS and Hypermobility Comes Up So Often
EDS is a connective tissue disorder, and many connective tissue conditions do have known genetic markers. That’s why testing is frequently discussed. In this post, we’ll explain what genetic testing can actually identify, why it doesn’t rule out hypermobility, and when it truly adds value. Understanding these limits can save you time, money, and emotional energy.
The Big Gap: Hypermobile EDS Has No Known Gene
The most common type of EDS is hypermobile EDS (hEDS). Currently, there is no identified genetic marker for hEDS. That means genetic testing cannot confirm or exclude it. A negative genetic test does not mean you aren’t hypermobile. It simply means science hasn’t caught up yet.
When Genetic Testing Is Helpful
Genetic testing can be extremely important for rarer forms of EDS. Types like classical or vascular EDS do have known genetic variants. Testing may also be appropriate if there are red flags such as organ rupture, very stretchy skin, a strong family history of severe complications early in life, or early cardiovascular events. In these cases, testing helps guide safety, monitoring, and family planning.
Why I Don’t Recommend Testing for Most Patients
For the majority of hypermobile patients, genetic testing does not change diagnosis or treatment. It often adds stress and wastes time and money without providing clarity. I typically recommend testing only when there are specific concerns for other connective tissue disorders, such as Marfan syndrome or osteogenesis imperfecta. Otherwise, clinical evaluation remains the most meaningful tool. Currently hEDS is a clinical diagnosis meaning that it is a checklist and if you get enough “points” on the checklist then you meet the criteria for hypermobile EDS. Although this is also far from 100% accurate that’s what we have at this time. There is a movement to revise the diagnostic guidelines sometime in 2026 so hopefully we will get better tests soon.
Negative Results Do Not Mean “Nothing Is Wrong”
This is the most important takeaway. A negative genetic test does not invalidate your symptoms. It does not erase joint instability, pain, fatigue, or autonomic symptoms. Hypermobile EDS and HSD are clinical diagnoses, based on history, physical exam, and lived experience — not lab results alone.
Knowledge Is Power, Not a Requirement
You don’t need a genetic test to deserve care, support, or treatment. Understanding the limits of testing can help you make informed choices and advocate more confidently. Your body is not “less real” because a test came back normal. Sometimes, the most powerful answers come from listening — not testing.
Share Your Story
Have you had genetic testing done? Did it bring clarity or more questions? Your experience may help someone else navigate this decision with less fear and more confidence.
Connect with Us
Follow us on social media for more tips, updates, and support:
Ready to Take the Next Step?
For those seeking personalized guidance, our 1-on-1 coaching program offers tailored support to address your specific needs. With expert advice and a comprehensive plan, you’ll gain the tools and confidence to manage your condition effectively. Learn more and sign up here.
Thank you for being part of the Bendy Club. Together, we can make a difference!
Warm regards,
The Hypermobile Solutions Team
References
Home. The Ehlers Danlos Society. https://www.ehlers-danlos.com/
What is HSD?. The Ehlers Danlos Society. https://www.ehlers-danlos.com/what-is-hsd/
What is eds?. The Ehlers Danlos Society. https://www.ehlers-danlos.com/what-is-eds/
Jovin, D., Atwal, P., Herman, K., Block, N., Maxwell, A. J., Mitakides, J., Maitland, A. M., Saperstein, D., Hamilton, M., Schofield, J., Koby, M., Klinge, P., McElroy, A., Bluestein, L., Chopra, P., Tishler, J., Pocinki, A. G., Varga, J., Dempsey, T., … Lane, K. (2020). Disjointed: Navigating the diagnosis and management of Hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Hidden Stripes Publications, Inc.
Smith, C., & Wicks, D. (2017). Understanding Hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder: (previously known as Ehlers-Danlos Syndrome Hypermobility Type & Joint Hypermobility Syndrome, respectively). Redcliff-House Publications.
Cox, C. (2022). Holding it all together when you’re Hypermobile. Journey2Joy
Afrin, L. B. (2016). Never bet against Occam: Mast cell activation disease and the modern epidemics of chronic illness and medical complexity. Sisters Media, LLC.
Freeman, K., Goldstein, D. S., & Thompson, C. R. (2025). The dysautonomia project: Understanding autonomic nervous system disorders (2nd ed.). Bardolf.
Disclaimer
This blog is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional health care services, including the giving of medical advice, and no provider/patient relationship is formed. The use of information on this blog or materials linked from this blog is at the user’s own risk. The content of this blog is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions.